HIV Management in Russia vs. USA
In this White Paper, our Global Antiviral team examine the infrastructure of the healthcare systems in Russia and the USA with respect to the management of HIV patients.
HIV / AIDS remains a key public health concern in Russia. Although government funding for ARV treatment and HIV research has increased in the last 10 years, the system is still under-funded and offers basic treatment options in comparison to the USA. Discriminatory attitudes also create a barrier, leading to low treatment rates and poor management of the disease.
In their latest White Paper, our Global Antiviral team has used both primary and secondary research to compare the infrastructure of the healthcare systems in Russia and the USA, seeking to understand the differences in the epidemic and how this influences the treatment management of patients.
Download